LeadStory
HealthMedical Research

Al Jazeera

US approves two gene therapies for sickle cell disease

Al Jazeera ·
Al Jazeera
Al Jazeera

The U.S. Food and Drug Administration (FDA) on Friday approved two gene therapies for sickle cell disease, making one of them the first treatment in the United States based on the Nobel Prize-winning CRISPR gene editing technology.